NAV

What this means for you

Registered since 13 Aug 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 13 Aug 2023).

Record

Serial number

85314870

Registration number

4384443

Mark type

Stylized text

Filed

06 May 2011

Published for opposition

15 May 2012

Registered

13 Aug 2013

Next maintenance due

13 Aug 2023

Attorney of record

William R. Samuels

Goods and services

• Class 005 — Pharmaceuticals: Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and adenoviruses for gene delivery to biological cells that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy

Owner

• REGENXBIO INC., Rockville, MD, US
• Regenx Biosciences, LLC, Washington, DC, US
• Regenx Biosciences, LLC, Washington, DC, US
• Regenx Biosciences, LLC, Washington, DC, US

Prosecution history

• 12 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 12 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 12 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 12 Dec 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 12 Dec 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 23 Jul 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 23 Jul 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 23 Jul 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 16 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
• 16 Jul 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
• 10 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
• 11 Jan 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
• 11 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 13 Jul 2023 — TEAS SECTION 8 & 9 RECEIVED
• 17 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED